Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes

H Reinhard; Peter Karl Jacobsen; Marianne Lajer; N Pedersen; Nils Billestrup; Thomas Mandrup-Poulsen; H-H Parving; Pia Rossing

doi:10.1007/s00125-010-1843-4

Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes

H Reinhard, Peter Karl Jacobsen, Marianne Lajer, N Pedersen, Nils Billestrup, Thomas Mandrup-Poulsen, H-H Parving, Pia Rossing

35 Citationer (Scopus)

Abstract

Endothelial progenitor cells (EPC) augment vascular repair and neovascularisation. Patients with type 2 diabetes have reduced EPC and increased risk of cardiovascular disease (CVD), which is reduced by multifactorial intervention. Our aim, therefore, was to evaluate in type 2 diabetic patients whether the numbers of EPC derived from peripheral blood mononuclear cells is influenced by a multifactorial treatment strategy.

Originalsprog	Engelsk
Tidsskrift	Diabetologia
Vol/bind	53
Udgave nummer	10
Sider (fra-til)	2129-33
Antal sider	5
ISSN	0012-186X
DOI	https://doi.org/10.1007/s00125-010-1843-4
Status	Udgivet - 1 okt. 2010

Adgang til dokumentet

10.1007/s00125-010-1843-4

Citationsformater

@article{baaf5baeda214ee68c5184a365bbc1a1,

title = "Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes",

abstract = "Endothelial progenitor cells (EPC) augment vascular repair and neovascularisation. Patients with type 2 diabetes have reduced EPC and increased risk of cardiovascular disease (CVD), which is reduced by multifactorial intervention. Our aim, therefore, was to evaluate in type 2 diabetic patients whether the numbers of EPC derived from peripheral blood mononuclear cells is influenced by a multifactorial treatment strategy.",

author = "H Reinhard and Jacobsen, {Peter Karl} and Marianne Lajer and N Pedersen and Nils Billestrup and Thomas Mandrup-Poulsen and H-H Parving and Pia Rossing",

year = "2010",

month = oct,

day = "1",

doi = "10.1007/s00125-010-1843-4",

language = "English",

volume = "53",

pages = "2129--33",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "10",

}

TY - JOUR

T1 - Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes

AU - Reinhard, H

AU - Jacobsen, Peter Karl

AU - Lajer, Marianne

AU - Pedersen, N

AU - Billestrup, Nils

AU - Mandrup-Poulsen, Thomas

AU - Parving, H-H

AU - Rossing, Pia

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Endothelial progenitor cells (EPC) augment vascular repair and neovascularisation. Patients with type 2 diabetes have reduced EPC and increased risk of cardiovascular disease (CVD), which is reduced by multifactorial intervention. Our aim, therefore, was to evaluate in type 2 diabetic patients whether the numbers of EPC derived from peripheral blood mononuclear cells is influenced by a multifactorial treatment strategy.

AB - Endothelial progenitor cells (EPC) augment vascular repair and neovascularisation. Patients with type 2 diabetes have reduced EPC and increased risk of cardiovascular disease (CVD), which is reduced by multifactorial intervention. Our aim, therefore, was to evaluate in type 2 diabetic patients whether the numbers of EPC derived from peripheral blood mononuclear cells is influenced by a multifactorial treatment strategy.

U2 - 10.1007/s00125-010-1843-4

DO - 10.1007/s00125-010-1843-4

M3 - Journal article

C2 - 20607514

SN - 0012-186X

VL - 53

SP - 2129

EP - 2133

JO - Diabetologia

JF - Diabetologia

IS - 10

ER -

Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater